Article Link: FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia MORRISTOWN, N.J., Jan....
Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector
Article Link: Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector PARSIPPANY, N.J.–(BUSINESS WIRE) Janu...
FDA Approves Trijardy XR (empagliflozin/linagliptin/metformin) for Type 2 Diabetes in Adults
Article Link: FDA Approves Trijardy XR (empagliflozin/linagliptin/metformin) for Type 2 Diabetes in Adults RIDGEFIELD, Conn., and INDIANA...
FDA Approves Merck’s Dificid (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older
Article Link: FDA Approves Merck’s Dificid (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older KENILWOR...
FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma
Article Link: FDA Approves Tazverik (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma CAMBRIDGE, Mass.–(BUSINES...
FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
Article Link: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED) DUBLIN–(BUSINESS WIRE)–...
FDA Approves Ozempic (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease
Article Link: FDA Approves Ozempic (semaglutide) for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes and Known Heart Disease ...
FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia
Article Link: FDA Approves Numbrino (cocaine hydrochloride) Nasal Solution for Nasal Anesthesia PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ ...
FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment
Article Link: FDA Approves Valtoco (diazepam nasal spray) as a Seizure Rescue Treatment SAN DIEGO, CA – January 13, 2020 – Neurelis, Inc....
FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
Article Link: FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal St...
